What is the drug of choice and recommended regimen for uncomplicated brucellosis in an adult patient?

Drug of Choice for Brucellosis

First-Line Treatment Recommendation

For uncomplicated brucellosis in adults, doxycycline 100 mg twice daily for 6 weeks combined with streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks is the drug of choice, offering the lowest relapse rates (AI recommendation). 1, 2

Treatment Algorithm

Primary Regimen (Lowest Relapse Rate)

• Doxycycline-Streptomycin (DOX-STR): Doxycycline 100 mg orally twice daily for 6 weeks PLUS streptomycin 15 mg/kg intramuscularly daily for 2-3 weeks 1, 2
• This combination achieves a relapse rate of approximately 5.3% compared to 16% with doxycycline-rifampicin 3
• Carries an AI recommendation (good evidence, should always be offered) 1

Alternative First-Line Regimen (When Oral Therapy Preferred)

• Doxycycline-Rifampicin (DOX-RIF): Doxycycline 100 mg orally twice daily for 6 weeks PLUS rifampicin 600-900 mg as a single morning dose for 6 weeks 1, 2
• Also carries an AI recommendation but has higher relapse rates (16% vs 5.3%) 3
• Preferred when avoiding intramuscular injections is necessary or when streptomycin is unavailable 2
• Critical caveat: In regions where tuberculosis is endemic, rifampicin use may contribute to mycobacterial resistance 2, 4

Alternative Aminoglycoside Regimen

• Doxycycline-Gentamicin (DOX-GENT): Doxycycline 100 mg orally twice daily for 6 weeks PLUS gentamicin 5 mg/kg parenterally daily in a single dose for 7 days 1, 2
• Carries a BI recommendation (moderate evidence, should generally be offered) 1
• Offers the advantage of wider gentamicin availability and shorter parenteral therapy duration compared to streptomycin 2
• Relapse rates of 10-20% have been reported, approximately 5% higher than DOX-STR 2

Second-Line Options (Lower Quality Evidence)

Trimethoprim-Sulfamethoxazole Regimens

• TMP-SMX: 800+160 mg twice daily for 6 weeks carries a CII recommendation (poor evidence, optional) 1
• When used as monotherapy for 45 days, relapse rates reached 46% 1
• May be considered as a cost-effective alternative in resource-limited settings or as part of combination therapy 2

Quinolone-Containing Regimens

• Ofloxacin or ciprofloxacin should be reserved as second or third agents in combination regimens 2
• Carry a CII recommendation due to higher cost and risk of promoting antimicrobial resistance 2
• Comparable efficacy to doxycycline-rifampicin but with higher relapse rates 5, 6

Critical Treatment Principles

Duration Matters

• Standard duration is 6 weeks for uncomplicated brucellosis 1, 2, 7
• Shorter durations (less than 4 weeks) are associated with unacceptably high relapse rates of 22% 5
• Even with optimal treatment, relapse rates range from 5-15% 2, 4

Monotherapy is Inadequate

• Monotherapy has historically shown relapse rates of 2-39%, with one well-designed trial showing 13% relapse rate versus 4.8% for combination therapy 1, 5
• Combination therapy is imperative to prevent relapse and resistance development 1

Common Pitfalls to Avoid

• Do not use rifampicin-based regimens as first choice when streptomycin is available, as they have significantly higher relapse rates (16% vs 5.3%) 3
• Do not shorten aminoglycoside duration below recommended: Gentamicin requires 7 days, streptomycin requires 14-21 days 1, 2
• Do not use TMP-SMX as monotherapy: relapse rates reach 46% 1
• Do not stop treatment early even if symptoms resolve, as clinical improvement precedes microbiological cure 4

Special Clinical Situations Requiring Modified Approach

Complicated Brucellosis (Spondylitis/Sacroiliitis)

• Extend treatment duration to 12 weeks (3 months) 4
• Aminoglycoside-containing regimens are superior to rifampicin-containing ones for osteoarticular involvement 4, 8
• Obtain MRI confirmation of spinal involvement in any patient with back pain 4, 8

Neurobrucellosis

• Consider ceftriaxone-based regimens or doxycycline plus rifampicin with an aminoglycoside 8
• Requires extended treatment duration beyond standard 6 weeks 8